In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
OverviewVyalev is approved by the U.S. Food and Drug Administration (FDA) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. This treatment is intended for individuals who experience…
Join